Hypertension in thoracic transplant recipients

被引:22
作者
Jenkins, GH [1 ]
Singer, DRJ [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Natl Heart & Lung Inst,Transplant Unit, Heart Sci Ctr,Sch Med,Royal Brompton & Harefield, Harefield UB9 6JH, Middx, England
关键词
transplantation; blood pressure; circadian; immunosuppression; dietary sodium; cyclosporin A;
D O I
10.1038/sj.jhh.1000710
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
There are many mechanisms underlying the hypertension which occurs after thoracic transplantation. Previous disease, effects of cyclosporin, tacrolimus and steroid immunosuppression and cardiac denervation are major contributory factors, Abnormal sodium and water balance is an important common mediating faster. A new approach is clearly needed for classifying the severity of hypertension in these patients taking into account day-night variation and total blood pressure (BP) load: This would allow improved strategies for investigation and treatment. The evidence suggests that ambulatory BP measurements should be included in the assessment of initial severity of pose-transplant hypertension as well as response to treatment, Further studies are needed to look at the effects of raised clinic and 24-h ambulatory BP and its treatment on longer term morbidity and mortality in thoracic transplant patients.
引用
收藏
页码:813 / 823
页数:11
相关论文
共 124 条
[1]   Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat [J].
Abassi, ZA ;
Pieruzzi, F ;
Nakhoul, F ;
Keiser, HR .
HYPERTENSION, 1996, 27 (05) :1140-1148
[2]  
Ader JL, 1996, J AM SOC NEPHROL, V7, P1145
[3]   DOBUTAMINE STRESS-INDUCED ANGINA IN PATIENTS WITH DENERVATED CARDIAC TRANSPLANTS - CLINICAL AND ANGIOGRAPHIC CORRELATES [J].
AKOSAH, K ;
OLSOVSKY, M ;
MOHANTY, PK .
CHEST, 1995, 108 (03) :695-700
[4]  
Andoh TF, 1997, SEMIN NEPHROL, V17, P34
[5]   FUNCTIONAL AND STRUCTURAL CHARACTERISTICS OF EXPERIMENTAL FK-506 NEPHROTOXICITY [J].
ANDOH, TF ;
BURDMANN, EA ;
LINDSLEY, J ;
HOUGHTON, DC ;
WILLIAM, M ;
BENNETT, WM .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (09) :646-654
[6]   Attenuated microvascular perfusion and reactivity in cardiac transplant recipients treated with cyclosporine [J].
Andreassen, AK ;
Simonsen, S ;
Bjornerheim, R ;
Kvernebo, K .
INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL, 1995, 15 (03) :117-124
[7]  
ANGERMANN CE, 1989, Z KARDIOL, V78, P228
[8]  
Arbustini E, 1997, G Ital Cardiol, V27, P985
[9]  
ARMITAGE JM, 1993, J THORAC CARDIOV SUR, V105, P464
[10]   PRELIMINARY EXPERIENCE WITH FK506 IN THORACIC TRANSPLANTATION [J].
ARMITAGE, JM ;
KORMOS, RL ;
FUNG, J ;
LAVEE, J ;
FRICKER, FJ ;
GRIFFITH, BP ;
STUART, RS ;
MARRONE, GC ;
HARDESTY, RL ;
TODO, S ;
TZAKIS, A ;
STARZL, TE .
TRANSPLANTATION, 1991, 52 (01) :164-167